MILANO ( – Kolinpharma has signed a non-recourse factoring contract with Banca Ifis for a total amount of 2 million euro, therefore bringing bank credit lines to 3.35 million euro. In addition to improving its bank rating, the transaction will make available to the AIM company additional resources to pursue strategic lines focused on investments in research and development of new products and new pharmaceutical forms, in addition to strengthening the sales network. “This contract confirms the interest that has been built up for innovative SMEs, not only from the capital market, but also from the banking world – said the president Rita Paola Petrelli – The signing of the agreement will allow the company to acquire additional liquidity to be allocated to operational activities, in view of the expected growth that will support our strategic development path”.